Colon-targeted active agent delivery carrier and uses thereof
US-2024390501-A1 · Nov 28, 2024 · US
US9028806B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9028806-B2 |
| Application number | US-201013320453-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 12, 2010 |
| Priority date | May 15, 2009 |
| Publication date | May 12, 2015 |
| Grant date | May 12, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a batch method for impregnating a nonporous polymer pharmaceutical carrier with an active substance, characterized in that said method includes the following consecutive steps: a) mixing the active substance and the nonporous polymer pharmaceutical carrier, the pharmaceutical carrier being in a solid form and insoluble in supercritical CO 2 and not being non-crosslinked polyvinylpyrrolidone; b) performing a step of molecular diffusion in the absence of water by contacting, in a static mode without agitation, the mixture obtained in step a) with supercritical CO 2 at a pressure of 80 to 170 bars, at a temperature of 31 to 90° C. for 1 to 6 hours; c) recovering the polymer pharmaceutical carrier impregnated with the active substance obtained in step b), the impregnated pharmaceutical carrier being nonporous and being in a solid form and the active substance being in an amorphous form, the method being implemented in the absence of an additional solvent. The invention further relates to a polymer pharmaceutical carrier in a nonporous solid form impregnated with an active substance characterized in that said carrier can be obtained by the method according to the present invention, in that the active substance is in an amorphous form and is water-soluble, and in that the polymer pharmaceutical carrier is not non-crosslinked polyvinylpyrrolidone and is insoluble in supercritical CO 2 .
Opening claim text (preview).
The invention claimed is: 1. Batch method for impregnating a polymeric pharmaceutical carrier with an active substance, wherein it comprises the following consecutive steps: a) mixing the active substance and the non-porous polymeric pharmaceutical carrier chosen from disintegrating agents, filler agents, or mixtures thereof, the pharmaceutical carrier being in solid form and insoluble in supercritical CO 2 and not being non-cross-linked polyvinylpyrrolidone; b) performing a mo…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.